JLE

European Journal of Dermatology

MENU

Psychosocial burden and body mass index are associated with dermatology-related quality of life in psoriasis patients Volume 30, numéro 2, March-April 2020

Illustrations


  • Figure 1

  • Figure 2

Tableaux

Auteurs
1 Department of Dermatology, Venereology and Allergology, University Hospital Essen, University Duisburg-Essen, Hufelandstr. 55, 45122 EssenGermany
2 Institute of Psychology, Justus-Liebig University Gießen, Otto-Behaghel-Straße 10, Philosophikum I, 35394 GießenGermany
3 Hautärzte RÜ 143, Rüttenscheider Str. 143, 45130 EssenGermany
4 LVR-Hospital Essen, Department of Psychiatry and Psychotherapy, Medical Faculty, University of Duisburg-Essen, Virchowstr. 174, 45147 EssenGermany
5 Institute of Medical Psychology and Behavioral Immunobiology, University Hospital Essen, University of Duisburg-Essen, 45122 EssenGermany
6 Department of Clinical Neuroscience, Osher Center for Integrative Medicine, Karolinska Institutet, 171 77 StockholmSweden
* Reprints

Background: Scientific evidence indicates that inflammatory processes may be involved in the progression of both psoriasis and depression via elevated peripheral proinflammatory cytokines. Objectives: The aim of our study was to assess the association among psychological burden, depressive symptoms and proinflammatory mediators in psoriasis patients. Materials and Methods: Forty psoriasis patients were recruited from the Department of Dermatology, University Hospital Essen. In addition to the Psoriasis Area and Severity Index (PASI), mental and physical health were explored using different questionnaires. Furthermore, proinflammatory cytokines were analysed. Results: Patients in the high PASI group showed reduced Dermatology Life Quality Index (DLQI), higher body mass index (BMI), elevated CRP levels as well as impaired physical aspects of quality of life. Regression analyses revealed that somatic and anxiety symptoms accounted for more than 32% of the variance in DLQI, independent of PASI and cytokine levels. Conclusion: The data indicate somatic and anxiety symptoms, as well as BMI, to be closely linked to dermatology-related quality of life.